Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
Clinical trial NCT01705145 · COMPLETED
Trial details
- NCT number
- NCT01705145
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-03-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.